12-121856304-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000289004.8(HPD):c.324+20G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000369 in 1,604,710 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 2 hom. )
Consequence
HPD
ENST00000289004.8 intron
ENST00000289004.8 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.265
Genes affected
HPD (HGNC:5147): (4-hydroxyphenylpyruvate dioxygenase) The protein encoded by this gene is an enzyme in the catabolic pathway of tyrosine. The encoded protein catalyzes the conversion of 4-hydroxyphenylpyruvate to homogentisate. Defects in this gene are a cause of tyrosinemia type 3 (TYRO3) and hawkinsinuria (HAWK). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 12-121856304-C-T is Benign according to our data. Variant chr12-121856304-C-T is described in ClinVar as [Benign]. Clinvar id is 1166574.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPD | NM_002150.3 | c.324+20G>A | intron_variant | ENST00000289004.8 | NP_002141.2 | |||
HPD | NM_001171993.2 | c.207+20G>A | intron_variant | NP_001165464.1 | ||||
LOC105370035 | XR_002957437.2 | n.52C>T | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPD | ENST00000289004.8 | c.324+20G>A | intron_variant | 1 | NM_002150.3 | ENSP00000289004.4 | ||||
HPD | ENST00000543163.5 | c.207+20G>A | intron_variant | 5 | ENSP00000441677.1 | |||||
ENSG00000256811 | ENST00000543848.1 | n.46C>T | non_coding_transcript_exon_variant | 1/3 | 3 | |||||
HPD | ENST00000542159.2 | n.360+20G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00201 AC: 306AN: 152192Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
306
AN:
152192
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000620 AC: 156AN: 251426Hom.: 2 AF XY: 0.000412 AC XY: 56AN XY: 135900
GnomAD3 exomes
AF:
AC:
156
AN:
251426
Hom.:
AF XY:
AC XY:
56
AN XY:
135900
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000196 AC: 284AN: 1452400Hom.: 2 Cov.: 29 AF XY: 0.000155 AC XY: 112AN XY: 723194
GnomAD4 exome
AF:
AC:
284
AN:
1452400
Hom.:
Cov.:
29
AF XY:
AC XY:
112
AN XY:
723194
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00202 AC: 308AN: 152310Hom.: 0 Cov.: 32 AF XY: 0.00203 AC XY: 151AN XY: 74474
GnomAD4 genome
AF:
AC:
308
AN:
152310
Hom.:
Cov.:
32
AF XY:
AC XY:
151
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Tyrosinemia type III;C2931042:Hawkinsinuria Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at